Blood Pressure Management in Acute Intracerebral Hemorrhage

Acute Phase Blood Pressure Targets

• The American Heart Association recommends targeting a systolic blood pressure of 130-140 mmHg within 1 hour of presentation for patients with acute spontaneous intracerebral hemorrhage presenting with systolic blood pressure between 150-220 mmHg, and maintaining this for at least 7 days 1, 2
• Initiate treatment within 6 hours of symptom onset for optimal benefit, with the goal of achieving the target blood pressure range within 1 hour of presentation 1, 2
• The American Heart Association suggests that reducing systolic blood pressure below 130 mmHg is potentially harmful and associated with worse outcomes 1, 2

Rationale and Supporting Evidence

• Elevated blood pressure is associated with hematoma expansion, neurological deterioration, and worse outcomes, according to the American Heart Association 1, 6
• The American Heart Association states that perfusion CT studies show blood pressure reduction to 130-140 mmHg does not significantly reduce cerebral blood flow in the perihematoma region 1

Implementation Strategy

• The American Heart Association recommends beginning treatment as soon as possible after diagnosis, ideally within 2 hours of intracerebral hemorrhage onset, to minimize hematoma expansion and improve outcomes 1, 2
• The American Heart Association suggests using any antihypertensive with rapid onset and short duration to facilitate easy titration, such as IV nicardipine, which was used in the ATACH-2 trial 1

Cerebral Perfusion Pressure Considerations

• The American Heart Association recommends maintaining cerebral perfusion pressure (CPP) ≥60 mmHg at all times, especially with elevated intracranial pressure (ICP), to ensure adequate cerebral blood flow 6, 2

Long-Term Management

• The American Heart Association recommends transitioning to a target blood pressure of <130/80 mmHg for secondary prevention of intracerebral hemorrhage recurrence, as hypertension is the most important modifiable risk factor for recurrence 9, 2
• The PROGRESS trial showed that blood pressure lowering significantly reduced the risk of first intracerebral hemorrhage (adjusted HR 0.44, 95% CI 0.28-0.69) 9